Weight Loss  +  Wellness
Home > The Ozempic Shortage Is Over—But Here’s Why Compounded Versions Still Matter

The Ozempic Shortage Is Over—But Here’s Why Compounded Versions Still Matter

The Ozempic shortage is officially over—but that doesn’t mean compounded GLP-1s are going away. In this article, we explore why many patients still choose compounded semaglutide for affordability, flexibility, and convenience—even as brand-name options return to shelves.

For over a year, patients across the U.S. struggled to access Ozempic, the name-brand semaglutide injection used for type 2 diabetes and off-label weight loss. Shortages disrupted treatment plans and fueled the rise of telehealth and compounding alternatives.


But as of Spring 2025, the FDA has confirmed: the Ozempic shortage is officially over.

So… now what?

The FDA Says Supply Is Back—But Demand Is Still Sky High

Novo Nordisk has ramped up production, especially for Ozempic’s lower-dose pens, and the drug is now more reliably available in most pharmacies. However, access doesn’t automatically mean affordability or convenience.

Patients still face:

  • Sticker shock for cash-pay prescriptions (often $900–$1,200/month)
  • Long pharmacy waitlists in some areas
  • Insurance headaches or denials for weight loss use

Can Compounding Pharmacies Still Sell Semaglutide?

Yes, they can—but only under specific conditions.

Under FDA regulations, compounding pharmacies can legally produce compounded semaglutide only if the commercially manufactured version (Ozempic, Wegovy) is listed on the FDA’s shortage list.

Here’s the nuance:

  • As of May 2025, Ozempic (semaglutide for injection) is no longer on the list.
  • However, Wegovy (semaglutide for weight loss) still is in limited supply in certain dose strengths.
  • Many compounding pharmacies continue to offer compounded semaglutide for weight loss, citing that the branded version for this use case remains limited.

Additionally, some providers formulate semaglutide base or semaglutide sodium under state board guidelines and can continue selling as long as they do not misrepresent it as Ozempic.

Why Patients Still Choose Compounded Options

Even with brand-name supply restored, patients are sticking with compounders for good reasons:

  • Weight loss-focused protocols: Many telehealth clinics offer support, coaching, and labs
  • Lower cost: Often 50–75% cheaper than Ozempic
  • Custom dosing: Blends with B12 or titration flexibility
  • Faster shipping: No delays or pharmacy coordination

The Bottom Line

Yes, the Ozempic shortage is technically over—but compounded semaglutide continues to serve a vital role for patients seeking affordability, customization, and fast access through telehealth.

If you’re ready to start or stay on semaglutide, comparing your options is the smartest move. Branded meds may be back—but the convenience and price point of compounded GLP-1s are here to stay.

Looking for GLP-1 options that fit your lifestyle and budget? Click here to compare top providers.

Compare dozens of GLP-1 providers

Save time and money finding the best GLP-1 provider for you. Our search tool lets you compare providers using criteria tailored to fit your needs.

Compare dozens of
GLP-1 providers

Save time and money finding the best GLP-1 provider for you. Our search tool lets you compare providers using criteria tailored to fit your needs.

More from the Ultimate Wellness Scroll

Telemeds for me logo white
The Platform is an online aggregator that helps users locate telehealth providers who may prescribe and deliver GLP-1 medications. Telemedsforme.com is not a healthcare provider and does not provide medical services, diagnosis or treatment. We only facilitate the discovery of potential telehealth providers (collectively, the “Third-Party Providers”).

Information on this site is for reference only and doesn't replace professional medical advice. For health-related inquiries, consult your doctor.

*Disclaimer: The FDA-approved brand name drugs, such as Wegovy®, and Ozempic® are exclusively available from the Novo Nordisk® company. Mounjaro® and Zepbound® is exclusively available from Eli Lilly and Company®. TelemedsForMe does not claim any affiliation with, or endorsement from, the above mentioned products or entities.
©2025 TelemedsForMe. All rights reserved.